Search Results - "Candás Estébanez, Beatriz"

Refine Results
  1. 1
  2. 2

    Polygenic Risk of Hypertriglyceridemia Is Modified by BMI by Esteve-Luque, Virginia, Fanlo-Maresma, Marta, Padró-Miquel, Ariadna, Corbella, Emili, Rivas-Regaira, Maite, Pintó, Xavier, Candás-Estébanez, Beatriz

    “…Background: Genetic risk scores (GRSs) have partially improved the understanding of the etiology of moderate hypertriglyceridemia (HTG), which until recently…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia by Esteve-Luque, Virginia, Padró-Miquel, Ariadna, Fanlo-Maresma, Marta, Corbella, Emili, Corbella, Xavier, Pintó, Xavier, Candás-Estébanez, Beatriz

    Published in Nutrients (01-02-2021)
    “…Lipid metabolism disorders, especially hypertriglyceridemia (HTG), are risk factors for non-alcoholic fatty liver disease (NAFLD). However, the association…”
    Get full text
    Journal Article
  5. 5

    Precipitated sdLDL: An easy method to estimate LDL particle size by Fernández‐Cidón, Bárbara, CandásEstébanez, Beatriz, Ribalta, Josep, Rock, Edmond, Guardiola‐Guionnet, Montserrat, Amigó, Núria, Padró‐Miquel, Ariadna, Alía‐Ramos, Pedro, Pintó‐Sala, Xavier

    Published in Journal of clinical laboratory analysis (01-07-2020)
    “…Background LDL‐C lowering is the main measure in cardiovascular disease prevention but a residual risk of ischemic events still remains. Alterations of…”
    Get full text
    Journal Article
  6. 6

    Study of common hypertriglyceridaemia genetic variants and subclinical atherosclerosis in a group of women with SLE and a control group by Fanlo-Maresma, Marta, Esteve-Luque, Virginia, Pintó, Xavier, Padró-Miquel, Ariadna, Corbella, Emili, Candás-Estébanez, Beatriz

    Published in Lupus science & medicine (23-08-2022)
    “…ObjectiveSLE is associated with increased cardiovascular risk (CVR). High serum concentrations of triglyceride-rich lipoproteins and apolipoprotein B-rich…”
    Get full text
    Journal Article
  7. 7

    Influence of 6 genetic variants on the efficacy of statins in patients with dyslipidemia by Cano‐Corres, Ruth, CandásEstébanez, Beatriz, Padró‐Miquel, Ariadna, Fanlo‐Maresma, Marta, Pintó, Xavier, Alía‐Ramos, Pedro

    Published in Journal of clinical laboratory analysis (01-10-2018)
    “…Background Patients with dyslipidemia are often treated with statins to reduce lipids and hence cardiovascular risk, but treatment response is variable, partly…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Removing Lipemia in Serum/Plasma Samples: A Multicenter Study by Castro-Castro, María José, Candás-Estébanez, Beatriz, Esteban-Salán, Margarita, Calmarza, Pilar, Arrobas-Velilla, Teresa, Romero-Román, Carlos, Pocoví-Mieras, Miguel, Aguilar-Doreste, José Ángel

    Published in Annals of laboratory medicine (01-11-2018)
    “…Lipemia, a significant source of analytical errors in clinical laboratory settings, should be removed prior to measuring biochemical parameters. We…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    APOE Variants E2, E3, and E4 Can Be Miscalled By Classical PCR‐RFLP When The Christchurch Variant Is Also Present by CandásEstébanez, Beatriz, Padró‐Miquel, Ariadna, Ruiz‐Iruela, Cristina, Corbella‐Inglés, Emili, Pintó‐Sala, Xavier, Alía‐Ramos, Pedro

    Published in Journal of clinical laboratory analysis (01-03-2017)
    “…Background The APOE Christchurch (APOECh) is a rare variant (c.543C>A) in codon 154. It was first described in an E2 patient with type III dyslipidemia, and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    HLA-B57: 01 genotyping in the prevention of hypersensitivity to abacavir: 5 years of experience by Ruiz-Iruela, Cristina, Padullés-Zamora, Núria, Podzamczer-Palter, Daniel, Alonso-Pastor, Arnald, Candás-Estébanez, Beatriz, Alía-Ramos, Pedro, Padró-Miquel, Ariadna

    Published in Pharmacogenetics and genomics (01-08-2016)
    “…INTRODUCTIONMost of the cost-effectiveness analyses are based on estimations to make decisions on the future implementation of a test. However, the model…”
    Get full text
    Journal Article
  15. 15

    Meeting report: present state of molecular genetics in clinical laboratories. Report on the VII European Symposium on Clinical Laboratory and In Vitro Diagnostic Industry in Barcelona by Padró-Miquel, Ariadna, Candás-Estébanez, Beatriz

    Published in Clinical chemistry and laboratory medicine (01-02-2015)
    “…The VII European Symposium of the Clinical Laboratory and In Vitro Diagnostic Industry, co-organized between the Catalan Association for Clinical Laboratory…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Lack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study by Antonio Navarro-Alcaraz, Juan Tiraboschi, Carmen Gómez, Beatriz Candas-Estébanez, María Saumoy, Arkaitz Imaz, Daniel Podzamczer

    Published in HIV research & clinical practice (04-05-2019)
    “…Objective: To assess the effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) supplementation on bone metabolism in HIV-infected patients presenting with…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Estimation of alert and change limits and its application in the plausibility control by Castro-Castro, María José, Dot-Bach, Dolors, Candás-Estébanez, Beatriz, Cano-Corres, Ruth, Fuentes-Arderiu, Xavier

    Published in Accreditation and quality assurance (01-12-2011)
    “…In the clinical laboratory, one of the most objective ways to perform the final review of patients’ measured values is the use of computerized plausibility…”
    Get full text
    Journal Article